Clinical Trial: Effect of Hyaluronidase in Different Doses Added to Bupivacaine on TAB Block Quality During CS

U.S., Feb. 22 -- ClinicalTrials.gov registry received information related to the study (NCT06839391) titled 'Effect of Hyaluronidase in Different Doses Added to Bupivacaine on TAB Block Quality During CS' on Feb. 17.

Brief Summary: evaluate the efficacy of hyaluronidase in different doses as an adjuvant to bupivacaine in ultrasound-guided TAB block during CS

Study Start Date: March, 2025

Study Type: INTERVENTIONAL

Condition: Tab Block Qaulity

Intervention: DRUG: Hyaluronidase

Effect of hyaluronidases in different doses added to bupivacaine on quality of ultrasound-guided TAB block during CS ,

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Benha University

Information provided by (Responsible Party): Mohamed said MOSTAFA elmeligy...